These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10939846)

  • 21. Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons.
    Yan JJ; Hsueh PR; Lu JJ; Chang FY; Ko WC; Wu JJ
    J Antimicrob Chemother; 2006 Sep; 58(3):530-6. PubMed ID: 16816399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Pseudomonas aeruginosa clinical strains harboring the bla(VIM-2) metallo-beta-lactamase gene in Akita Prefecture, Japan.
    Yatsuyanagi J; Saito S; Ito Y; Ohta K; Kato J; Harata S; Suzuki N; Amano K
    Jpn J Infect Dis; 2004 Jun; 57(3):130-2. PubMed ID: 15218228
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-{beta}-lactamase from different Italian hospitals.
    Riccio ML; Pallecchi L; Docquier JD; Cresti S; Catania MR; Pagani L; Lagatolla C; Cornaglia G; Fontana R; Rossolini GM
    Antimicrob Agents Chemother; 2005 Jan; 49(1):104-10. PubMed ID: 15616282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of VIM-5 metallo-beta-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey.
    Bahar G; Mazzariol A; Koncan R; Mert A; Fontana R; Rossolini GM; Cornaglia G
    J Antimicrob Chemother; 2004 Jul; 54(1):282-3. PubMed ID: 15190017
    [No Abstract]   [Full Text] [Related]  

  • 26. Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential.
    Mushtaq S; Ge Y; Livermore DM
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3086-92. PubMed ID: 15273124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemic outbreak of Pseudomonas aeruginosa carbepenem-resistant producing metallo-beta-lactamase].
    Jimeno A; Alcalde MM; Blázquez A
    Rev Clin Esp; 2011 Apr; 211(4):187-91. PubMed ID: 21429485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to carbapenems among Pseudomonas aeruginosa isolated from patients of transplant wards.
    Mlynarczyk G; Sawicka-Grzelak A; Szymanek K; Buczkowska T; Pazik J; Durlik M; Pacholczyk M; Lagiewska B; Chmura A; Paczek L; Mlynarczyk A
    Transplant Proc; 2009 Oct; 41(8):3258-60. PubMed ID: 19857725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel VIM-type metallo-beta-lactamase (VIM-14) in a Pseudomonas aeruginosa clinical isolate from a neonatal intensive care unit.
    Mazzariol A; Mammina C; Koncan R; Di Gaetano V; Di Carlo P; Cipolla D; Corsello G; Cornaglia G
    Clin Microbiol Infect; 2011 May; 17(5):722-4. PubMed ID: 21521413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in Brazil.
    Viana Vieira V; Lourenço da Fonseca E; Paulo Vincente AC
    Clin Microbiol Infect; 2005 Nov; 11(11):937. PubMed ID: 16216114
    [No Abstract]   [Full Text] [Related]  

  • 32. bla(IMP-9) and its association with large plasmids carried by Pseudomonas aeruginosa isolates from the People's Republic of China.
    Xiong J; Hynes MF; Ye H; Chen H; Yang Y; M'zali F; Hawkey PM
    Antimicrob Agents Chemother; 2006 Jan; 50(1):355-8. PubMed ID: 16377710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype.
    Pollini S; Fiscarelli E; Mugnaioli C; Di Pilato V; Ricciotti G; Neri AS; Rossolini GM
    Clin Microbiol Infect; 2011 Aug; 17(8):1272-5. PubMed ID: 21375657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential selection of IMP and VIM metallo-beta-lactamases by imipenem in Pseudomonas aeruginosa.
    Walsh F; Bracher S; Turner P; Amyes S
    Chemotherapy; 2007; 53(6):407-9. PubMed ID: 17934261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary.
    Libisch B; Watine J; Balogh B; Gacs M; Muzslay M; Szabó G; Füzi M
    Res Microbiol; 2008 Apr; 159(3):162-8. PubMed ID: 18280707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Italian metallo-beta-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme.
    Toleman MA; Biedenbach D; Bennett DM; Jones RN; Walsh TR
    J Antimicrob Chemother; 2005 Jan; 55(1):61-70. PubMed ID: 15574470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular typing and resistance mechanisms of carbapenem resistant Pseudomonas aeruginosa isolated from a Chinese surgical intensive care unit.
    Yi M; Wang P; Liu Y
    Chin Med J (Engl); 2014; 127(6):1071-6. PubMed ID: 24622437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of plasmid OXA and other β-lactamase genes among carbapenem-resistant isolates of Pseudomonas aeruginosa from the Clinical University Hospital in northeastern Poland.
    Sacha P; Michalska A; Ojdana D; Wieczorek P; Hauschild T; Majewski P; Tryniszewska E
    New Microbiol; 2015 Apr; 38(2):271-5. PubMed ID: 25938753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital.
    Sader HS; Reis AO; Silbert S; Gales AC
    Clin Microbiol Infect; 2005 Jan; 11(1):73-6. PubMed ID: 15649310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
    Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
    J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.